Brind.
  1. Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.
  2. Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.
  3. Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.
  4. Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.

Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.

6 reports, 4 independent Updated Jun 23
Gone quiet Reached 3 outlets in its first 24 hours
Reports
6
Developments
6
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.

Who's involved

What this event is mainly about
Ardelyx (United States)Kyowa KirinChina

How it developed

Newest first. Tap a step to see who reported it.
  1. Raab was appointed President and CEO of Ardelyx on August 5, 2025.Sub-event
  2. Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.Sub-event
  3. Ardelyx secured FDA approval for treatments and expanded its global reach via a partnership.1 source
  4. Ardelyx secured US product approvals, while the partnership led to a new drug application in China.1 source
  5. Multiple companies achieved drug approvals and commercialization milestones in the US, China, and Japan.1 source
  6. IBSRELA, a flagship therapy for Ardelyx, has entered its third year following FDA approval.1 source

Keep exploring

Part of

Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership. All 1 developments

Within Ardelyx has received FDA-approved treatments and strengthened its global reach through a partnership.

The entities involved

Coverage

Newest first; wire copies grouped
  • yahoo.com
  • Insider MonkeyArdelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal We recently published 10 Best Biotech Stocks to Buy Under $10. Ardelyx, Inc. stands fourth among them. Ardelyx, Inc. (NASDAQ:ARDX)
  • GlobeNewswireArdelyx to Participate in Upcoming Investor Conferences WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,
  • Insider MonkeyArdelyx (ARDX) Rated as ‘Overweight’ at Cantor Fitzgerald amid Ibsrela Sales Growth Expectation Ardelyx Inc. (NASDAQ:ARDX) is one of the penny stocks that will skyrocket. On July 7, analysts at Canto
  • GlobeNewswireArdelyx to Report Second Quarter 2025 Financial Results on August 4, 2025 Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq:
  • BarchartThis Small-Cap Stock Could 10x by 2030, But It’s Not for the Faint of Heart Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant prog